Epidemiology of Klebsiella Pneumoniae in China
- Conditions
- Klebsiella Pneumoniae Infection
- Interventions
- Other: no intervention
- Registration Number
- NCT03598543
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Brief Summary
Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.
- Detailed Description
All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- new confirmed community-onset or noscomial infection of Klebsiella pneumoniae infection
- Age<18, or >85 years old; Mixed infection of Klebsiella pneumoniae and other microbes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Carbapenem-Sensitive K. pneumoniae no intervention Any patients with clinical confirmed Carbapenem-Sensitive Klebsiella pneumoniae infection. Carbapenem-Resistant K. pneumoniae no intervention Patients with clinical confirmed Carbapenem-Resistant Klebsiella pneumoniae infection.
- Primary Outcome Measures
Name Time Method CRKP infection 6 months Culture postitive results confirmed the infection of CRKP
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sir Run Run Shaw Hospital
🇨🇳Hangzhou, Zhejiang, China